Refractory facial Darier's disease treated with daylight photodynamic therapy
Keywords: 
Materias Investigacion::Ciencias de la vida
Refractory facial Darier's
Photodynamic therapy
Issue Date: 
2022
Publisher: 
Wiley
ISSN: 
1610-0387
Note: 
This is an open access article under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License
Citation: 
Morelló-Vicente, A. (Ana); Antoñanzas, J. (Javier); Estenaga, Á. (Ángela); et al. "Refractory facial Darier's disease treated with daylight photodynamic therapy". Journal of the German Society of Dermatology. 20 (12), 2022, 1633 - 1635
Abstract
Darier’s disease (DD) is an infrequent autosomal dominant skin disorder caused by a mutation of the ATP2A2 gene on chromosome 12 [1]. Mutations in this gene result in abnorma-lities in keratinocyte cell-cell adhesion producing an alterati-on of the keratinization of the skin, which clinically presents with dyskeratotic papules mostly affecting seborrheic and in-tertriginous areas. Palmoplantar and nail involvement is often present [1–3]. As a wide range of treatments have been propo-sed for this skin disorder with different results, the manage-ment of this disease is still a challenge for the dermatologist.

Files in This Item:
Thumbnail
File
J Deutsche Derma Gesell - 2022 - Morell ‐Vicente - Refractory facial Darier s disease treated with daylight photodynamic.pdf
Description
Size
488.28 kB
Format
Adobe PDF


Statistics and impact
0 citas en
0 citas en

Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.